Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF6005/06
CompoundCebranopadol
Trials sponsorGrünenthal GmbH
Trial phase2
Brief titleEfficacy and safety of GRT6005 in patients with chronic low back pain
IndicationLow back pain
UTN
CTG IDNCT01725087
CTIS ID (former EudraCT)2012-001920-36
Trial statusCompleted
FPINovember 30, 2012
LPOJuly 10, 2014
CountriesFrance
GenderAll
Age40 to 70 years
ResultsYes
Pubmed
Documents